Enveric Biosciences, Inc. - 10-Q filing on 2012-11-13

Net Operating Loss Carryforwards	9 Months Ended
Sep. 30, 2012
Notes to Financial Statements
Note 3 - Net Operating Loss Carryforwards	At September 30, 2012, we had net operating loss carry-forwards for Federal income tax purposes of approximately $9,500,000 which were available to offset future Federal taxable income, if any, through 2031. These net operating loss carry forwards are subject to an annual limitation of approximately $1,000,000. Utilization of these loss carryforwards is subject to further limitation as a result of change in ownership of the Company, as defined by Federal tax law.

Net Operating Loss Carryforwards

9 Months Ended

Sep. 30, 2012

Note 3 - Net Operating Loss Carryforwards

At September 30, 2012, we had net operating loss carry-forwards for Federal income tax purposes of approximately $9,500,000 which were available to offset future Federal taxable income, if any, through 2031. These net operating loss carry forwards are subject to an annual limitation of approximately $1,000,000. Utilization of these loss carryforwards is subject to further limitation as a result of change in ownership of the Company, as defined by Federal tax law.